| Adeel Ijaz, MD | |
|
46857 Garfield Rd, Macomb, MI 48044-5225 | |
| (586) 532-8500 | |
| (586) 532-1515 |
| Full Name | Adeel Ijaz |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 46857 Garfield Rd, Macomb, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386695724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | N2574 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialylsis Care Of Greenville | Greenville, TX | Dialysis facility |
| Sng - Greenville Dialysis Center Lp | Greenville, TX | Dialysis facility |
| Hunt Regional Medical Center | Greenville, TX | Hospital |
| Baylor Scott And White Medical Center Mckinney | Mc kinney, TX | Hospital |
| Texas Health Presbyterian Hospital Allen | Allen, TX | Hospital |
| Medical Center Of Mckinney | Mckinney, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lonestar Nephrology Care Pllc | 2769712066 | 3 |
News Archive
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
The Journal of Visualized Experiments (JoVE) is partnering with Stanford University's Medicine X Conference to present groundbreaking research on the intersection between healthcare and social media.
Study results by faculty members of the University of Texas School of Public Health at Houston suggests that the older, cheaper diuretics remain the drug of choice for both black and non-black patients in treating high blood pressure and reducing risk of heart disease, and confirms earlier findings that diuretics rather than newer, more expensive drugs such as ACE inhibitors, calcium channel blockers, or beta blockers should be preferred as a first therapy for most patients.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
› Verified 1 days ago
| Entity Name | Lonestar Nephrology Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679128417 PECOS PAC ID: 2769712066 Enrollment ID: O20190930002936 |
News Archive
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
The Journal of Visualized Experiments (JoVE) is partnering with Stanford University's Medicine X Conference to present groundbreaking research on the intersection between healthcare and social media.
Study results by faculty members of the University of Texas School of Public Health at Houston suggests that the older, cheaper diuretics remain the drug of choice for both black and non-black patients in treating high blood pressure and reducing risk of heart disease, and confirms earlier findings that diuretics rather than newer, more expensive drugs such as ACE inhibitors, calcium channel blockers, or beta blockers should be preferred as a first therapy for most patients.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adeel Ijaz, MD 4201 Medical Center Dr, Suite 260, Mckinney, TX 75069-1766 Ph: (972) 547-6969 | Adeel Ijaz, MD 46857 Garfield Rd, Macomb, MI 48044-5225 Ph: (586) 532-8500 |
News Archive
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
The Journal of Visualized Experiments (JoVE) is partnering with Stanford University's Medicine X Conference to present groundbreaking research on the intersection between healthcare and social media.
Study results by faculty members of the University of Texas School of Public Health at Houston suggests that the older, cheaper diuretics remain the drug of choice for both black and non-black patients in treating high blood pressure and reducing risk of heart disease, and confirms earlier findings that diuretics rather than newer, more expensive drugs such as ACE inhibitors, calcium channel blockers, or beta blockers should be preferred as a first therapy for most patients.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
› Verified 1 days ago
Ferah Adil Dalaly, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 17900 23 Mile Rd, Suite 303, Macomb, MI 48044 Phone: 586-868-9800 Fax: 586-868-9801 | |
Brian D Young, DO Nephrology Medicare: Medicare Enrolled Practice Location: 46857 Garfield Rd, Macomb, MI 48044 Phone: 586-532-8500 Fax: 586-532-1515 | |
Massimiliano P Vitale, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 17900 23 Mile Rd, Suite 303, Macomb, MI 48044 Phone: 586-868-9800 Fax: 586-868-9801 | |
Dr. Zain Azzo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 46591 Romeo Plank Rd Ste 133, Macomb, MI 48044 Phone: 586-580-3062 Fax: 586-580-3143 | |
Jaspreet K Hehar, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 46591 Romeo Plank Rd Ste 131, Macomb, MI 48044 Phone: 586-226-6080 Fax: 586-226-6001 | |
Dr. Michael Stephen Rozwadowski, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18423 Cracklewood Dr, Macomb, MI 48042 Phone: 586-850-9581 |